ATTD

New data shows long-term use of an AID system powered by Dexcom CGM can safely maintain improvements in glycaemic outcomes for up to two years1. Real-world evidence demonstrates reduction in …

Envector Co., Ltd. PARSIPPANY, N.J., March 6, 2024 (GLOBE NEWSWIRE) — Envector Corporation (“Envector”) (Nasdaq: EMBC), a global diabetes care company with a 100-year heritage in insulin delivery, announced today …

Few fields can claim to embrace the evolving role of technology in patient care as diabetes management. Nowhere is this desire to improve patient care and quality of life more …